| MRSA carrier (n = 121) | Non-MRSA carrier (n = 733) | p value |
---|---|---|---|
Age (mean ± SD) | 84.3 ± 8.9 | 83.0 ± 10.1 | 0.144 |
Sex (male) | 35 (28.9%) | 246 (33.6%) | 0.368 |
Underlying diseases | Â | Â | Â |
Chronic cerebral conditions a | 25 (20.7%) | 84 (11.5%) | 0.008 |
Presence of | Â | Â | Â |
Nasogastric tube | 13 (10.7%) | 39 (5.3%) | 0.035 |
Urinary catheter | 5 (4.1%) | 5 (0.7%) | 0.005 |
Antibiotics therapy within 3 months of MRSA screening | Â | Â | Â |
β -lactam/β-lactamase inhibitors | 6 (5.0%) | 15 (2.0%) | 0.110 |
Area (square feet) per person b | 108.8 ± 20.1 | 113.0 ± 19.0 | 0.031 |